title: Dalbavancin (Dalvance) for the treatment of acute bacterial skin infection.
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.forename: Kelly A
authors.initials: KA
authors.lastname: Foley
authors.forename: William
authors.initials: W
authors.lastname: Abramovits
authors.forename: Ted
authors.initials: T
authors.lastname: Rosen
mesh_terms: D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D017334:Teicoplanin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D017334:Teicoplanin; C469289:dalbavancin